HOME | CUMC | DEPARTMENT OF MEDICINE | JOBS | RASCAL | PHOTO GALLERY | CONTACT US

• Message from the Division Chief
• News
• Events
• About Us
  • People
  • Administration
  • Students and Alumni
• Charitable Giving
  • Donate online

• Research
  • Biology
    • Vasopressin, Stem cells,
      Nerve Agents, Cocaine
  • Chemistry
  • Organic Synthesis Collaborative Center
  • Molecular Robotics
    • Center for molecular cybernetics

Vasopressin Publications

• Oliver JA, Landry DW. Endogenous and exogenous vasopressin in shock. Curr Opin Crit Care. 2007 Aug;13(4):376-82
• van der Zee S, Thompson A, Zimmerman R, Lin J, Huan Y, Braskett M, Sciacca RR, Landry DW, Oliver JA. Vasopressin administration facilitates fluid removal during hemodialysis. Kidney Int. 2007 Feb;71(4):318-24. Epub 2006 Sep 27.
• Landry DW, Oliver JA. Vasopressin and relativity: on the matter of deficiency and sensitivity. Crit Care Med. 2006 Apr;34(4):1275-7.
• Malay MB, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC Jr, Sciacca RR, Oliver JA, Landry DW. Heterogeneity of the vasoconstrictor effect of vasopressin in septic shock. Crit Care Med. 2004 Jun;32(6):1327-31.
• Holmes CL, Landry DW, Granton JT. Science Review: Vasopressin and the cardiovascular system part 2 – clinical physiology. Crit Care. 2004 Feb;8(1):15-23. Epub 2003 Jun 26.
• Landry DW, Oliver JA.  Insights into shock. Sci Am. 2004 Feb;290(2):36-41.
• Holmes CL, Landry DW, Granton JT. Science review: Vasopressin and the cardiovascular system part 1—receptor physiology. Crit Care. 2003 Dec;7(6):427-34. Epub 2003 Jun 26.
• Robin JK, Oliver JA, Landry DW. Vasopressin deficiency in the syndrome of irreversible shock. J Trauma. 2003 May;54(5 Suppl):S149-54.
• Morales DL, Garrido MJ, Madigan JD, Helman DN, Faber J, Williams MR, Landry DW, Oz MC. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg. 2003 Mar;75(3):926-30.
• Oliver JA, Landry DW.  Patient with a sudden drop in blood pressure. Crit Care Med. 2003 Jan;31(1):326-7.
• Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001 Aug 23;345(8):588-95.
• Gold J, Cullinane S, Chen J, Seo S, Oz MC, Oliver JA, Landry DW. Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure. Am J Cardiol. 2000 Feb 15;85(4):506-8, A11.
• Gold JA, Cullinane S, Chen J, Oz MC, Oliver JA, Landry DW. Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension. Crit Care Med. 2000 Jan;28(1):249-52.
• Morales DL, Gregg D, Helman DN, Williams MR, Naka Y, Landry DW, Oz MC. Arginine vasopressin in the treatment of 50 patients with postcardiotomy vasodilatory shock. Ann Thorac Surg. 2000 Jan;69(1):102-6.
• Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards NM, Oz MC, Landry DW. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation. 1999 Nov 9;100(19 Suppl):II244-6.
• Rosenzweig EB, Starc TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME. Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation. 1999 Nov 9;100(19 Suppl):II182-6.
• Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999 Oct;47(4):699-703; discussion 703-5.
• Argenziano M, Chen JM, Cullinane S, Choudhri AF, Rose EA, Smith CR, Edwards NM, Landry DW, Oz MC.  Arginine vasopressin in the management of vasodilatory hypotension after cardiac transplantation. J Heart Lung Transplant. 1999 Aug;18(8):814-7.
• Morales D, Madigan J, Cullinane S, Chen J, Heath M, Oz M, Oliver JA, Landry DW.  Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock. Circulation. 1999 Jul 20;100(3):226-9.
• Argenziano M, Chen JM, Choudhri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr, Rose EA, Landry DW, Oz MC. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998 Dec;116(6):973-80.
• Mets B, Michler RE, Delphin ED, Oz MC, Landry DW. Refractory vasodilation after cardiopulmonary bypass for heart transplantation in recipients on combined amiodarone and angiotensin-converting enzyme inhibitor therapy: a role for vasopressin administration. J Cardiothorac Vasc Anesth. 1998 Jun;12(3):326-9.
• Argenziano M, Choudhri AF, Oz MC, Rose EA, Smith CR, Landry DW. A prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation. 1997 Nov 4;96(9 Suppl):II-286-90.
• Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997 Aug;25(8):1279-82.
• Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC,  Oliver JA. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997 Mar 4;95(5):1122-5.

  < Back